Quest Diagnostics, Inc [DGX] stock is trading at $168.82, up 1.44%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The DGX shares have lost -1.66% over the last week, with a monthly amount glided 1.13%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Quest Diagnostics, Inc [NYSE: DGX] stock has seen the most recent analyst activity on March 04, 2025, when Citigroup downgraded its rating to a Neutral but kept the price target unchanged to $185 for it. Previously, Leerink Partners upgraded its rating to Outperform on January 06, 2025, and elevated its price target to $174. On December 17, 2024, upgrade upgraded it’s rating to Overweight and revised its price target to $172 on the stock. Robert W. Baird upgraded its rating to a Outperform and raised its price target to $182 on October 23, 2024. In a note dated July 10, 2024, Citigroup upgraded an Buy rating on this stock and boosted its target price from $145 to $165.
Quest Diagnostics, Inc [DGX] stock has fluctuated between $125.09 and $178.87 over the past year. Currently, Wall Street analysts expect the stock to reach $178.14 within the next 12 months. Quest Diagnostics, Inc [NYSE: DGX] shares were valued at $168.82 at the most recent close of the market. An investor can expect a potential return of 5.52% based on the average DGX price forecast.
Analyzing the DGX fundamentals
Quest Diagnostics, Inc [NYSE:DGX] reported sales of 9.87B for the trailing twelve months, which represents a growth of 14.55%. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.13 and Total Capital is 0.1. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 166.58 points at the first support level, and at 164.34 for the second support level. However, for the 1st resistance point, the stock is sitting at 170.24, and for the 2nd resistance point, it is at 171.66.
Ratios To Look Out For
For context, Quest Diagnostics, Inc’s Current Ratio is 1.10. As well, the Quick Ratio is 1.02, while the Cash Ratio is 0.25. Considering the valuation of this stock, the price to sales ratio is 1.90, the price to book ratio is 2.76 and price to earnings (TTM) ratio is 21.93.
Transactions by insiders
Recent insider trading involved Doherty Catherine T., EVP, Regional Businesses, that happened on Mar 05 ’25 when 5370.0 shares were sold. EVP, Regional Businesses, Doherty Catherine T. completed a deal on Mar 04 ’25 to sell 716.0 shares. Meanwhile, SVP & General Counsel PREVOZNIK MICHAEL E sold 592.0 shares on Mar 04 ’25.
